SMi Group reports: Key pressing questions on rapid microbial methods, contamination control, sterility assurance and environmental monitoring will be addressed at the Microbiology East Coast Conference in Boston this April 2022. Microbiology remains an essential […]
SMi Reports: Chemaxon release an interview prior to joining the SMi’s 3rd Annual AI in Drug Discovery Conference on 14-15 March 2022 in London as a key sponsor. In less than 2 weeks time, SMi’s […]
SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device conferences, the 2022 event will provide […]
Delivery Innovations in Formulation and Device Design for Enhanced Subcutaneous As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of […]
Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) researchers have identified a potential drug candidate, larazotide acetate, to treat serious Covid-19 complication, multi-inflammatory syndrome (MIS-C) in children. A rare, severe and possibly life-threatening […]